Evidence map›Paper›PMID 35743619›Full record

ArticleJournal of clinical medicine2022

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist.

Giada Crescioli, Roberto Bonaiuti, Renato Corradetti, Guido Mannaioni, Alfredo Vannacci, Niccolò Lombardi

Abstract readEditorial
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Pharmacoepidemiology: An Overview.Journal of clinical medicine · 2023
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Giada CrescioliPharmacovigilance and Pharmacoepidemiology Research Unit, Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.ORCID 0000-0002-1071-6120
Roberto BonaiutiPharmacovigilance and Pharmacoepidemiology Research Unit, Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.
Renato CorradettiPharmacovigilance and Pharmacoepidemiology Research Unit, Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.
Guido MannaioniPharmacovigilance and Pharmacoepidemiology Research Unit, Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.
Alfredo VannacciPharmacovigilance and Pharmacoepidemiology Research Unit, Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.ORCID 0000-0001-5259-2026
Niccolò LombardiPharmacovigilance and Pharmacoepidemiology Research Unit, Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.ORCID 0000-0002-9666-0438

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent years, particularly the COVID-19 pandemic, can be considered a turning point for pharmacovigilance and pharmacoepidemiology in terms of their role in drug safety and drug utilisation monitoring in clinical practice [...].

Identifiers

PMID35743619
PMCPMC9225198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.